Meningeal NeoplasmsMeningiomaSeizures
Dr. Devang J. Pastakia, MD
NPI1477602787PAC ID8628161106
- Part D claims, 2017
- 25
- Publications
- 10
- Clinical trials
- 6
- Hospital affiliations
- 1
- Medical group
- 1
- Practice address
- 1211 Medical Center Drive, Nashville, TN 37232
- Practice phone
- Call (615) 322-3454
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Pastakia's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Devang J. Pastakia is a pediatric hematology and oncology physician in Nashville, Tennessee
Dr. Pastakia practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.
Dr. Pastakia's NPI, 1477602787, was assigned on January 9, 2007. Dr. Pastakia graduated from Rutgers New Jersey Medical School in 2003. Dr. Pastakia holds Tennessee license MD47730.
NPI and contact details
- NPI
- 1477602787NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8628161106
- NPI enumeration date
- January 9, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (615) 322-3454
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Devang J. Pastakia practices at Vanderbilt University Medical Center in Nashville, Tennessee
Dr. Pastakia's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.
- Vanderbilt University Medical Center1211 Medical Center Drive, Nashville, TN 37232 · Davidson CountyPhone(615) 322-3454
Source: Dmand AI Affiliation Data
Dr. Devang J. Pastakia is affiliated with 2 sites of care and 1 medical group
Dr. Pastakia's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Pastakia to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Devang J. Pastakia's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pastakia practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Vanderbilt University Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Pastakia practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Vanderbilt University Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Devang J. Pastakia is one of 141 pediatric hematologys and oncology physicians in Tennessee
Pediatric hematology-oncology is Dr. Pastakia's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Pastakia is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Pastakia's licenses on file in 3 states: Tennessee, Alabama and Maryland.
Specialties and state licenses
- Pediatric hematology and oncology, TennesseePrimary
- Alabama license
- Pediatrics, Maryland
Pediatric hematologys and oncology physicians near Dr. Pastakia
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
141pediatric hematologys and oncology physicians in Tennessee22pediatric hematologys and oncology physicians in Nashville16pediatric hematologys and oncology physicians at Vanderbilt University Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Devang J. Pastakia's patients have a median age of 11
Across all payers, Dmand AI patient panel data puts Dr. Pastakia's median patient age at 11, with 50% women.
Dr. Pastakia's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 11
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. Devang J. Pastakia wrote 25 Medicare Part D claims in 2017
In 2017, Dr. Pastakia wrote 25 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $429 in total drug cost.
Part D claims, 201725
Drugs named by CMS2
Total drug cost$429
Dr. Pastakia's most prescribed drugs by claims, 2017
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
How Dr. Devang J. Pastakia takes part in Medicare
Dr. Pastakia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find pediatric hematologys and oncology physicians like Dr. Pastakia by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Devang J. Pastakia has 10 publications on record
Dmand AI links 10 papers to Dr. Pastakia, published from 2015 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Sarcoma. Dr. Pastakia has published most often in Appl Neuropsychol Child. Dr. Pastakia's most frequent co-authors are Adam J. Esbenshade, MD, Michael Christopher Dewan and Brigitte C. Widemann, MD.
Papers10
Years published2015 to 2025
Dr. Pastakia's papers by year, 2015 to 2025
Topics Dr. Pastakia writes about most
- Brain Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Sarcoma
Dr. Pastakia's most frequent co-authors
- Adam J. Esbenshade, MD3 shared papers
- Michael Christopher Dewan2 shared papers
- Brigitte C. Widemann, MD2 shared papers
Recent publications by Dr. Pastakia
Antineoplastic Combined Chemotherapy ProtocolsNeuroblastoma
Appl Neuropsychol Child
Brain NeoplasmsExecutive FunctionLearning
Pediatr Blood Cancer
Antineoplastic Combined Chemotherapy ProtocolsErlotinib HydrochlorideOligodendroglioma
See who Dr. Pastakia researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pastakia works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Devang J. Pastakia has worked on 6 clinical trials
Dmand AI links Dr. Pastakia to 6 clinical trials, 3 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Neuroblastoma, Ganglioneuroblastoma and Glioblastoma. Children's Oncology Group sponsors the most, 2.
Clinical trials with Dr. Pastakia by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Pastakia's trials
- Neuroblastoma
- Ganglioneuroblastoma
- Glioblastoma
- Medulloblastoma
- Neurofibromatosis 1
Investigators on the most trials with Dr. Pastakia
- Jill Catherine Beck, MD3 shared trials
- Don E. Eslin, MD3 shared trials
- James T. Felker, MD3 shared trials
Recent clinical trials with Dr. Pastakia
A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG) (opens in a new tab)
Active, not recruitingPhase 2
GlioblastomaAstrocytomaDabrafenib MesylateTrametinib Dimethyl SulfoxideRadiation Therapy
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma (opens in a new tab)
Active, not recruitingPhase 3
Neurofibromatosis 1NeurofibromatosesCarboplatinSelumetinib SulfateVincristine Sulfate
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma (opens in a new tab)
Active, not recruitingPhase 2
MedulloblastomaNeuroectodermal Tumors, PrimitiveRadiation TherapyCisplatinCyclophosphamide
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma (opens in a new tab)
Active, not recruitingPhase 3
GanglioneuroblastomaNeuroblastomaCarboplatinCyclophosphamideDoxorubicin Hydrochloride
Sarcoma, Clear CellCraniopharyngiomaGuided Therapy
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Devang J. Pastakia graduated from Rutgers New Jersey Medical School
Dr. Pastakia graduated from Rutgers New Jersey Medical School in 2003.
- Medical school
- Board certified in pediatric hematology-oncology
Source: Dmand AI Professional Profile Data
Dr. Devang J. Pastakia accepts plans from 14 insurance carriers
Dr. Pastakia is in network with 14 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
- United Healthcare
- Aetna
- Blue Cross Blue Shield of Michigan
- Elevance
- HCSC
- Alliant Health Plans
- Aspirus Health Plan
- AR State Medicaid
- +6 more carriersWith a free account
Plan types Dr. Pastakia accepts, by number of carriers
- HMO7
- PPO7
- EPO4
- POS4
- Medicaid3
- Medicare2
Source: Dmand AI Insurance Network Data
Sources for Dr. Devang J. Pastakia's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Devang J. Pastakia
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Devang J. Pastakia's NPI number?
Dr. Devang J. Pastakia's NPI number is 1477602787. It was assigned on January 9, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Devang J. Pastakia?
Dr. Devang J. Pastakia is a pediatric hematology and oncology physician in Nashville, Tennessee. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Devang J. Pastakia practice?
Dr. Pastakia practices at 1211 Medical Center Drive, Nashville, TN 37232. Dr. Pastakia's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dmand AI also links Dr. Pastakia to 1 group practice or clinic.
What is Dr. Devang J. Pastakia's office phone number?
The practice phone on file for Dr. Pastakia is (615) 322-3454.
What is Dr. Devang J. Pastakia's medical license number?
Dr. Pastakia holds Tennessee license MD47730, one of the licenses on file in 3 states.
Which states has Dr. Devang J. Pastakia been licensed in?
Dmand AI has state licenses on file for Dr. Pastakia in Tennessee (2011 to 2027), Alabama (2020) and Maryland (2006 to 2011).
Which hospitals is Dr. Devang J. Pastakia affiliated with?
Dr. Pastakia practices at Vanderbilt University Medical Center in Nashville, Tennessee.
What medical group is Dr. Devang J. Pastakia part of?
Dr. Pastakia is linked to Vanderbilt University Medical Center.
Does Dr. Devang J. Pastakia accept Medicare?
Yes. CMS lists Dr. Pastakia as accepting Medicare assignment.
Is Dr. Devang J. Pastakia board certified?
Yes. Dr. Pastakia is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Show 6 more questionsShow fewer questions
Where did Dr. Devang J. Pastakia go to medical school?
Dr. Pastakia graduated from Rutgers New Jersey Medical School in 2003.
What drugs does Dr. Devang J. Pastakia prescribe most?
In 2017 Medicare Part D data, Dr. Pastakia's most prescribed drugs by claims were Levetiracetam and Topiramate.
How long has Dr. Devang J. Pastakia been practicing?
Dr. Pastakia graduated from medical school in 2003, 23 years ago.
Does Dr. Devang J. Pastakia do research?
Dmand AI links 10 publications to Dr. Pastakia, published from 2015 to 2025. Dr. Pastakia has worked on 6 clinical trials.
Who does Dr. Devang J. Pastakia publish with?
Dr. Pastakia's most frequent co-authors are Adam J. Esbenshade, MD (3 shared papers), Michael Christopher Dewan (2 shared papers) and Brigitte C. Widemann, MD (2 shared papers).
What insurance does Dr. Devang J. Pastakia accept?
Dr. Pastakia is in network with 14 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card